Dr. James Murphy, PhD - Director, Research and Science, British American Tobacco (BAT) - Building A Smokeless World episode artwork

EPISODE · Mar 19, 2024 · 38 MIN

Dr. James Murphy, PhD - Director, Research and Science, British American Tobacco (BAT) - Building A Smokeless World

from Progress, Potential, and Possibilities Podcast / Show · host Ira Pastor / Dr. James Murphy

Send us Fan MailDr. James Murphy, PhD is Director, Research and Science, at British American Tobacco ( BAT - https://www.bat.com/DOCNLKSF.html ) where he plays a central role in leading the organization’s extensive research and development programs, which supports the company’s commitment to reducing the health impact of its business by offering consumers a range of alternative tobacco and nicotine products with a reduced risk profile. In this role, Dr Murphy leads the global Research and Science team, ensuring world-class science and best practice are applied to all aspects of BAT’s work and helps to deliver further scientific evidence that supports BAT’s New Categories products. Dr. Murphy has played a significant role in the development of BAT’s New Categories having been Product Development Lead for BAT’s first vapour launches and as Head of Reduced Risk Substantiation, he created and published the Group’s nine-step scientific assessment framework to assess BAT’s New Category products. Dr. Murphy brings two decades of experience and has held a number of senior roles in R&D, Operations and Marketing at BAT. He was most recently Executive Vice President, U.S. Scientific Research & Development, based at the headquarters of BAT’s U.S. business in Winston-Salem, North Carolina. Dr. Murphy has a BSc (Hons) in Chemistry from the Queen’s University of Belfast, a PhD in Synthetic Organic Chemistry and Polymer Chemistry from the University of Edinburgh, and did his Postdoctoral Studies in Sugar Based Synthetic Organic Chemistry Polymer Chemistry, at the Nara Institute of Science and Technology in Japan. Disclaimer: Reduced-risk product statements in this podcast are based on the weight of evidence and assuming a complete switch from cigarette smoking. These products are not risk-free and are addictive. BAT's products as sold in the U.S., including Vuse, Velo, Grizzly, Kodiak, and Camel Snus, are subject to Food and Drug Administration (FDA) regulation and no reduced-risk claims will be made as to these products without FDA clearance. Support the show

Episode metadata supplied by the publisher feed · Published Mar 19, 2024

Embed this episode

Send us Fan Mail Dr. James Murphy, PhD is Director, Research and Science, at British American Tobacco ( BAT - https://www.bat.com/DOCNLKSF.html ) where he plays a central role in leading the organization’s extensive research and development programs, which supports the company’s commitment to reducing the health impact of its business by offering consumers a range of alternative tobacco and nicotine products with a reduced risk profile. In this role, Dr Murphy leads the global Research and Sc...

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Dr. James Murphy, PhD - Director, Research and Science, British American Tobacco (BAT) - Building A Smokeless World

0:00 38:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Progress, Potential, and Possibilities Podcast / Show?

This episode is 38 minutes long.

When was this Progress, Potential, and Possibilities Podcast / Show episode published?

This episode was published on March 19, 2024.

Can I download this Progress, Potential, and Possibilities Podcast / Show episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!